Cargando…
Erratum to: Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888528/ https://www.ncbi.nlm.nih.gov/pubmed/33644624 http://dx.doi.org/10.1210/jendso/bvab015 |
| _version_ | 1783652182472523776 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7888528 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78885282021-02-25 Erratum to: Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease J Endocr Soc Erratum Oxford University Press 2021-02-17 /pmc/articles/PMC7888528/ /pubmed/33644624 http://dx.doi.org/10.1210/jendso/bvab015 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Erratum Erratum to: Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease |
| title | Erratum to: Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease |
| title_full | Erratum to: Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease |
| title_fullStr | Erratum to: Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease |
| title_full_unstemmed | Erratum to: Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease |
| title_short | Erratum to: Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease |
| title_sort | erratum to: serum t3 level and duration of minimum maintenance dose therapy predict relapse in methimazole-treated graves disease |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888528/ https://www.ncbi.nlm.nih.gov/pubmed/33644624 http://dx.doi.org/10.1210/jendso/bvab015 |